Leaders in Testing
Institutions with system-wide policies for DPD/DPYD testing prior to capecitabine/5-FU treatment
(Note, if you know of a clinic that is testing but not shown here, please contact us.)
Guiding the Way of Others to Improve the Standard of Care
Here is a “how to guide” to set up testing at your clinic
A Guide for Implementing DPYD Genotyping for Systemic Fluoropyrimidines into Clinical Practice
Read how sites have started testing at their cancer centers
Strategies for DPYD testing prior to fluoropyrimidine chemotherapy in the US
Help Shape the Future of Testing
If your site tests for DPYD prior to fluoropyrimidine treatment and you would like to contribute your de-identified patient data to this ongoing study of the benefits of testing, please enter your site information on this form and you will be contacted by Dr. Dan Hertz or the OPREC study team.
